The global active implantable medical devices market is set to exhibit huge expansion in the coming years, as per the estimates of the market research firm, P&S Intelligence. The market is being driven by the growing incidence of cardiovascular diseases and neurological disorders, booming geriatric population, rapid technological advancements, surging healthcare expenditure, and exhaustive research and development (R&D) being conducted in the domain. Additionally, the emergence of subcutaneous implantable cardioverter defibrillators is creating immense growth opportunities in the market.

Over the Access Report Overview on Active Implantable Medical Devices Market Demand

As per the World Health Organization (WHO), nearly 17.5 million people died across the world because of cardiovascular diseases in 2012, and this number is predicted to rise to 23.3 million by 2030. Besides, the growing occurrence of various neurological diseases such as Alzheimer’s disease, epilepsy, depression, fecal incontinence, and Parkinson’s disease, is also driving the market expansion. These disorders occur due to the improper functioning of the central nervous system. 

Apart from the aforementioned factors, the burgeoning requirement for neurostimulators is also fueling the growth of the active implantable medical devices market. Depending on product, the market is divided into implantable cardioverter defibrillators, neurostimulators, implantable cardiac pacemakers, implantable hearing devices, ventricular assist devices, and implantable heart monitors/insertable loop recorders categories. Amongst these, the implantable cardioverter defibrillators category dominated the market in 2016, because of the high incidence of cardiovascular diseases and the huge demand for compliance for technologically advanced systems.

Hence, it can be said with confidence that the market will boom in the coming years, primarily because of the rising incidence of neurological disorders and cardiovascular diseases, surging geriatric population, and the growing healthcare expenditure across the globe.